Updates on managing HER2-positive early breast cancer

Share :
Published: 16 Feb 2021
Views: 667
Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

Dr Javier Cortes speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about updates in managing patients with HER2-positive breast cancer.

Dr Cortes gives updates on newly approved drugs that are improving outcomes, results from recent trials and changes in best practice.

Dr Cortes closes by giving his advice for treating these patients based on recent developments.